CN101637472A - 一种新的头孢曲松复方抗生素及其临床应用 - Google Patents
一种新的头孢曲松复方抗生素及其临床应用 Download PDFInfo
- Publication number
- CN101637472A CN101637472A CN200810028346A CN200810028346A CN101637472A CN 101637472 A CN101637472 A CN 101637472A CN 200810028346 A CN200810028346 A CN 200810028346A CN 200810028346 A CN200810028346 A CN 200810028346A CN 101637472 A CN101637472 A CN 101637472A
- Authority
- CN
- China
- Prior art keywords
- ctz
- sbt
- effect
- antibiotic
- pae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810028346A CN101637472A (zh) | 2008-05-28 | 2008-05-28 | 一种新的头孢曲松复方抗生素及其临床应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810028346A CN101637472A (zh) | 2008-05-28 | 2008-05-28 | 一种新的头孢曲松复方抗生素及其临床应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101637472A true CN101637472A (zh) | 2010-02-03 |
Family
ID=41612773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810028346A Pending CN101637472A (zh) | 2008-05-28 | 2008-05-28 | 一种新的头孢曲松复方抗生素及其临床应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101637472A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106822147A (zh) * | 2016-11-03 | 2017-06-13 | 湘北威尔曼制药股份有限公司 | 一种头孢曲松钠和舒巴坦钠组合物、包含该组合物的药物制剂及其应用 |
-
2008
- 2008-05-28 CN CN200810028346A patent/CN101637472A/zh active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106822147A (zh) * | 2016-11-03 | 2017-06-13 | 湘北威尔曼制药股份有限公司 | 一种头孢曲松钠和舒巴坦钠组合物、包含该组合物的药物制剂及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Anguera et al. | Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles | |
MANGI et al. | Development of meningitis during cephalothin therapy | |
Philbrick et al. | Single-dose antibiotic treatment for uncomplicated urinary tract infections: Less for less? | |
Cabellos et al. | Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis | |
Cornick et al. | The antimicrobial susceptibility patterns of the Barteroides fragilis group in the United States, 1987 | |
CN109715156A (zh) | 用于治疗细菌感染的头孢布烯和克拉维酸的组合 | |
Reese et al. | Pharmacodynamics of intermittent and continuous infusion piperacillin/tazobactam and cefepime against extended-spectrum β-lactamase-producing organisms | |
CN104337826A (zh) | 大环内酯类化合物或其盐的应用及含其的药物组合物 | |
Nicolau et al. | Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations | |
CN101543499B (zh) | 一种天然化合物熊果酸在抗菌方面的应用 | |
CN107243008A (zh) | 吡唑并[1,5‑a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物 | |
Yogev et al. | In vitro and in vivo synergism between amoxicillin and clavulanic acid against ampicillin-resistant Haemophilus influenzae type b | |
CN101637472A (zh) | 一种新的头孢曲松复方抗生素及其临床应用 | |
Miller et al. | Penicillin-induced effects on streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci | |
ROBERTS et al. | Demethylchlortetracycline and Tetracycline: A Critical Comparison: In Vitro Activity, Serum Concentrations, and Effect of Serum Binding | |
CN115192593A (zh) | 柔红霉素在治疗多重耐药菌感染疾病中的应用 | |
Solomkin et al. | Principles of antibiotic therapy | |
Wilson et al. | In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus | |
Pérez-Trallero et al. | In-vitro, in-vivo and ex-vivo studies with oral beta-lactams against Streptococcus pneumoniae. | |
Connor et al. | In-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b | |
Yuswar et al. | Antibiotic rationality on pneumonia treatment to pediatric patients at Sultan Syarif Mohamad Alkadrie hospital Pontianak | |
Rosenblatt | Susceptibility testing of anaerobic bacteria | |
Steurer et al. | Efficacy and safety of cefdinir in the treatment of maxillary sinusitis | |
Bannatyne et al. | Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole | |
Burns et al. | Infections of the lower respiratory tract: treatment with amoxicillin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: XIANGBEI WELMAN PHARMACEUTICAL CO., LTD. Owner name: XIANGBEI WELMAN PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GUANGZHOU WELMAN PHARMACEUTICAL R + D CENTER Effective date: 20100702 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510075 BUILDING 13, NO.56, SHUIYIN ROAD, YUEXIU DISTRICT, GUANGZHOU CITY, GUANGDONG PROVINCE TO: 410331 LIUYANG MEDICAL BOILOGICAL INDUSTRIAL PARK, CHANGSHA |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100702 Address after: 410331 Liuyang pharmaceutical biological industry park, Changsha Applicant after: Xiangbei Welman Pharmaceutical Co., Ltd. Address before: 510075 Guangdong city of Guangzhou province Yuexiu District Shuiyin Road No. 56 building 13 Applicant before: Guangzhou Welman New Medicine Development Center Co., Ltd. Co-applicant before: Xiangbei Welman Pharmaceutical Co., Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20100203 |